The clinical efficacy of modified xiaoyaosan in the treatment of liver Qi stagnation-type chloasma from the starting point of liver

Chloasma (melasma) is a common pigmentary disorder characterized by hyperpigmented facial macules with a high recurrence rate. In Traditional Chinese Medicine, liver qi stagnation is considered a key pathogenesis. This study aimed to evaluate the clinical efficacy and safety of Modified Xiaoyaosan, a classical liver-soothing herbal formula, as an adjunct to conventional therapy in patients with liver qi stagnation-type chloasma. A retrospective analysis was conducted on 78 female patients diagnosed with liver qi stagnation-type chloasma who received treatment at our hospital. Based on their treatment regimens, patients were categorized into a control group (treated with vitamin C, vitamin E, and topical tranexamic acid) and a study group (treated with the same regimen plus Modified Xiaoyaosan) for a duration of 12 weeks. Clinical efficacy, skin lesion scores, VISIA skin imaging parameters, quality of life (assessed using the Dermatology Life Quality Index), serum oxidative stress markers (including superoxide dismutase and malondialdehyde), recurrence rate, and adverse events were retrospectively evaluated and compared between the 2 groups. The study group showed significantly higher total clinical efficacy (94.87% vs 79.49%, P < .05), greater improvement in skin lesion scores and VISIA parameters (P < .001), and lower Dermatology Life Quality Index scores at 4 and 12 weeks (P < .001). Serum superoxide dismutase levels increased while malondialdehyde levels decreased more significantly in the study group (P < .001). Recurrence rate was lower in the study group (2.56% vs 17.95%, P < .05), with no significant difference in adverse event rates. Modified Xiaoyaosan combined with conventional Western treatment effectively improves clinical symptoms, reduces oxidative stress, enhances skin quality and quality of life, and lowers recurrence in liver qi stagnation-type chloasma, with good safety and tolerability.

Authors

Institutions

Publication Details

Journal
Medicine
Published
2025-10-31
DOI
https://doi.org/10.1097/md.0000000000045517
Primary Topic
Dermatologic Treatments and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The clinical efficacy of modified xiaoyaosan in the treatment of liver Qi stagnation-type chloasma from the starting point of liver

K. Ma, Xiang-Lan Wang, Zhangjun Li, Qingqiang Xu
Medicine
Dermatologic Treatments and Research
article

The clinical efficacy of modified xiaoyaosan in the treatment of liver Qi stagnation-type chloasma from the starting point of liver

K. Ma, Xiang-Lan Wang, Zhangjun Li, Qingqiang Xu
article en

Abstract

Chloasma (melasma) is a common pigmentary disorder characterized by hyperpigmented facial macules with a high recurrence rate. In Traditional Chinese Medicine, liver qi stagnation is considered a key pathogenesis. This study aimed to evaluate the clinical efficacy and safety of Modified Xiaoyaosan, a classical liver-soothing herbal formula, as an adjunct to conventional therapy in patients with liver qi stagnation-type chloasma. A retrospective analysis was conducted on 78 female patients diagnosed with liver qi stagnation-type chloasma who received treatment at our hospital. Based on their treatment regimens, patients were categorized into a control group (treated with vitamin C, vitamin E, and topical tranexamic acid) and a study group (treated with the same regimen plus Modified Xiaoyaosan) for a duration of 12 weeks. Clinical efficacy, skin lesion scores, VISIA skin imaging parameters, quality of life (assessed using the Dermatology Life Quality Index), serum oxidative stress markers (including superoxide dismutase and malondialdehyde), recurrence rate, and adverse events were retrospectively evaluated and compared between the 2 groups. The study group showed significantly higher total clinical efficacy (94.87% vs 79.49%, P < .05), greater improvement in skin lesion scores and VISIA parameters (P < .001), and lower Dermatology Life Quality Index scores at 4 and 12 weeks (P < .001). Serum superoxide dismutase levels increased while malondialdehyde levels decreased more significantly in the study group (P < .001). Recurrence rate was lower in the study group (2.56% vs 17.95%, P < .05), with no significant difference in adverse event rates. Modified Xiaoyaosan combined with conventional Western treatment effectively improves clinical symptoms, reduces oxidative stress, enhances skin quality and quality of life, and lowers recurrence in liver qi stagnation-type chloasma, with good safety and tolerability.

MedicineVol. 104(44)
Second Affiliated Hospital of Xi'an Jiaotong University (CN), Shaanxi Provincial Hospital of Traditional Chinese Medicine (CN)
Openalex Percentile: Top 42%
Dermatologic Treatments and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.